1Zaia JA. Prevention and management of CMV-related problems after hematopoietic stem cell transplantation. Bone Marrow Transplant ,2002,29:633-638.
2Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR severity index for grading acute graft-versus-host disease:retrospective comparison with Glucksberg grade. Br J Haematol, 1997,97:855-864.
3Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med, 2002,78:257-262.
4Afessa B,Litzow MR,Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant,2001,28:425-434.
5Bourke SJ. Interstitial lung disease:Progress and Problems. Postgrad Med J,2006,82:494- 499.
6Krause H, Hebart H,Jahn G,et al. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant, 1997,19:1111-1116.
8Meyers JD, Flournoy N,Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis, 1986,153:478-488.
9Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant, 1994,14 ( Suppl 4) : S19-S28.
10King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med, 2005,172:268-279.
二级参考文献7
1Krause H,Hebart H,Jahn G,et al.Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease[].Bone Marrow Transplantation.1997
2Meyers JD,Flournoy N,Thomas ED.Risk Factors for cytomegalovirus infection after human bone marrow transplantation[].The Journal of Infectious Diseases.1986
3Emanuel D,Cunningham I,Jules-Elysee K,et al.Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin[].Annals of Internal Medicine.1988
4Glucksberg H,Storb R,Fefer A,et al.Clinical manifestation of graft-versus-host disease in human recipients of marrow from HLAmatched sibling donors[].Transplantation.1974
5Reusser P,Einsele H,Lee J,et al.Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation[].Blood.2002
6Atkinson K,Nivison-Smith I,Dodds A,et al.A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989[].Bone Marrow Transplantation.1998
7L nnqvist B,Ringdén O,Wahren B,et al.Cytomegalovirus infection associated with and preceding chronic graft-versus-host-disease[].Transplantation.1984
5DAWSON J K,FEWINS H E,DESMOND J,et al.Pre-dictors of progression of HRCT diagnosed fibrosing alve-olitis in patients with rheumatoid arthritis[J].AnnRheum Dis,2002,61:517-521.
6MORRELL M,FRASER V J,KOLLEF M H.Delayingthe empiric treatment of candida bloodstream infectionuntil positive blood culture results are obtained:apoten-tial risk factor for hospital mortality[J].Antimicrob A-gents Chemother,2005,49:3640-3645.
